Can I Take Two Muscle Relaxers at the Same Time?

Taking two muscle relaxants at the same time is almost never a good idea, and no prescribing guideline recommends it. These drugs work by dampening signals in the brain and spinal cord, so doubling them amplifies sedation, slows breathing, and raises the odds of a dangerous drop in blood pressure. Even combining two different muscle relaxants from different chemical families stacks their side effects rather than targeting pain more precisely. The risks go well beyond extra drowsiness, and the specifics depend on which drugs are involved.

Why Two Muscle Relaxants Do Not Work Like Two Aspirin

Most muscle relaxants sold in the United States, including cyclobenzaprine, tizanidine, carisoprodol, methocarbamol, and metaxalone, achieve their effect by turning down activity in the central nervous system. They are not like ibuprofen or acetaminophen, where one pill blocks a chemical pathway at the site of inflammation and a second pill blocks a different one. Instead, they broadly quiet neural signaling in the brain and spinal cord, which is why they cause drowsiness, dizziness, and slowed reflexes even at normal doses. Adding a second muscle relaxant does not give you a more targeted effect on your sore back; it gives your nervous system a deeper, less controlled shutdown.

Prescribers sometimes overlook the fact that “muscle relaxant” is an umbrella term covering two distinct drug classes: antispasticity agents like baclofen, tizanidine, and dantrolene, which treat conditions involving involuntary muscle tightness, and antispasmodic agents like cyclobenzaprine, which are used for ordinary musculoskeletal pain and spasm.¹ These categories have different mechanisms, but their central-nervous-system-depressant effects overlap heavily. Combining a drug from each class does not produce complementary therapy; it produces additive sedation.

Sedation, Confusion, and the Risk of Falls

The most immediate danger of doubling up is excessive sedation. At a single standard dose, most muscle relaxants already make you drowsy enough that driving is unsafe. Two at once can push you past drowsiness into confusion, disorientation, and loss of coordination. This matters beyond comfort: drug interactions involving muscle relaxants have been linked to unintentional traumatic injury through mechanisms that include disorientation, sedation, and altered mental states.²

For certain groups, the consequences are especially severe. People on hemodialysis who take muscle relaxants face a higher risk of altered mental status and falls compared to those who do not use the drugs at all.³ If a single dose already elevates fall risk in someone with compromised kidney function, a second dose makes matters considerably worse because the kidneys cannot clear the drug efficiently. The same logic applies to older adults and anyone with liver impairment, since most muscle relaxants are metabolized in the liver.

Respiratory Depression Is the Quietest Danger

Slowed breathing does not announce itself the way pain or dizziness does. You might simply drift into heavy sleep without realizing your breathing rate has dropped to a dangerous level. A large analysis of adverse events reported to the FDA found a strong safety signal linking baclofen to respiratory depression, and the risk climbs steeply when muscle relaxants are used together with opioids or other sedating drugs.⁴ While the biggest headlines involve opioid combinations, the underlying biology applies any time you layer one central-nervous-system depressant on top of another, including two muscle relaxants.

Baclofen deserves special mention because it works on GABA-B receptors, which are deeply involved in regulating muscle tone and breathing. At standard doses taken by mouth, respiratory depression is uncommon. But the effect becomes pronounced at higher-than-intended doses or when another sedating drug is onboard. Adding a second muscle relaxant to baclofen is pharmacologically similar to raising the dose of a single drug past its safe ceiling.

The “Triple Threat” Combination

In real-world prescribing, the scenario that worries researchers most is not two muscle relaxants together but the combination of a muscle relaxant with an opioid painkiller and a benzodiazepine (like alprazolam or diazepam). This trio has been nicknamed the “triple threat” in clinical literature for good reason. A study using national insurance claims found that people prescribed all three classes of drug together had dramatically higher odds of being hospitalized compared to nonusers.⁵ Even the “double threat” of an opioid plus a muscle relaxant carried substantially elevated hospitalization odds.

The concomitant use of opioids and muscle relaxants has specifically been flagged in opioid prescribing guidelines because of the additive depressant effect on the central nervous system.⁶ The pharmacological reasoning extends to pairing two muscle relaxants: both act on overlapping brain circuits, so stacking them mimics the risk profile of a multi-drug sedative cocktail. If you are already taking an opioid or a benzodiazepine and are considering adding a muscle relaxant, the calculus becomes even more fraught. The answer is not to take two muscle relaxants instead of adding one to your existing regimen; it is to talk to your prescriber about whether a muscle relaxant is safe in your specific combination at all.

Drug-Specific Hazards That Compound When You Double Up

Not all muscle relaxants carry the same risks, so two particular drugs together can create dangers that neither would pose alone. Here are the ones that matter most.

Cyclobenzaprine and Serotonin Syndrome

Cyclobenzaprine is the most commonly prescribed muscle relaxant in the United States, accounting for more than half of all muscle-relaxant prescriptions.⁷ It is structurally similar to older tricyclic antidepressants, which means it can boost serotonin levels in the brain. On its own, that is rarely a problem. But if you take cyclobenzaprine alongside another serotonin-enhancing drug, you risk serotonin syndrome: a potentially life-threatening condition marked by agitation, high fever, rapid heartbeat, muscle rigidity, and seizures. Case reports describe severe serotonin syndrome triggered by cyclobenzaprine in patients who were also taking an antidepressant.⁸ The clinical pharmacology literature specifically recommends watching for serotonin syndrome signs whenever cyclobenzaprine is used.⁹

Metaxalone, another common muscle relaxant, has also been linked to serotonin toxicity. In reported cases, a metaxalone overdose in someone also taking an SSRI antidepressant produced dangerously high body temperature, seizure-like activity, and extreme muscle rigidity.¹⁰ If you were to combine cyclobenzaprine and metaxalone, or take either one with an antidepressant, the serotonergic load could push you into dangerous territory.

Tizanidine and Heart Rhythm or Blood Pressure Problems

Tizanidine lowers blood pressure as a known side effect. It is metabolized by a liver enzyme called CYP1A2, and anything that inhibits that enzyme causes tizanidine levels to rise in the blood. A study of more than 1,600 patients found that those prescribed tizanidine along with a strong CYP1A2 inhibitor experienced severe drops in blood pressure significantly more often than a comparison group on cyclobenzaprine.¹¹ Common CYP1A2 inhibitors include the antibiotic ciprofloxacin and the antidepressant fluvoxamine, but the principle extends to any drug that competes for the same metabolic pathway, including certain other muscle relaxants processed through overlapping liver enzymes.

Tizanidine also affects heart rhythm. Animal research has demonstrated that it prolongs the QT interval, a measure of electrical activity in the heart that, when stretched, raises the risk of a potentially fatal arrhythmia.¹² Pairing tizanidine with another drug that also prolongs the QT interval, or simply taking more of it than intended by combining it with a second muscle relaxant, raises arrhythmia risk.

Carisoprodol and Its Built-In Abuse Risk

Carisoprodol stands apart from other muscle relaxants because its body breaks it down into meprobamate, a sedative with abuse potential similar to that of benzodiazepines.¹³ Its sedative effects are largely driven by meprobamate’s action at GABA receptors.¹⁴ Combining carisoprodol with any other central-nervous-system depressant is essentially combining two sedatives. The drug is already a controlled substance in the United States, and taking it alongside a second muscle relaxant (or, worse, alongside an opioid or a benzodiazepine) is one of the most dangerous combinations in the muscle-relaxant world.

What Overdose of a Single Muscle Relaxant Looks Like

Understanding the signs of an overdose from one muscle relaxant helps explain why doubling up is so risky: taking two drugs at once can mimic an overdose of one.

Cyclobenzaprine overdose presents much like a tricyclic antidepressant overdose, with altered mental status, rapid heart rate, and cardiac conduction abnormalities. Treatment in the emergency department follows overdose protocols designed for tricyclics.¹⁵ For tolperisone (used more commonly outside the U.S.), overdose data from poison-center reports showed that symptoms primarily involved the central nervous system: drowsiness, coma, seizures, and agitation, with some patients experiencing severe cardiovascular and respiratory effects.¹⁶ The point is that these drugs have a ceiling above which the body’s core systems start failing, and adding a second muscle relaxant effectively lowers that ceiling.

Withdrawal Is Another Reason Not to Juggle Multiple Muscle Relaxants

If you take one muscle relaxant regularly and add a second, you eventually face the question of how to stop either one. Several muscle relaxants carry withdrawal risks that prescribers do not always warn about.

Tizanidine withdrawal can produce a sudden adrenaline surge that leads to dangerously high blood pressure, rapid heart rate, and severe rebound spasticity. The syndrome is more likely in people who have been on higher doses, and stopping abruptly is not recommended.¹⁷ Carisoprodol withdrawal produces symptoms that closely resemble benzodiazepine withdrawal, including anxiety, tremors, insomnia, muscle twitching, and hallucinations, because what is really happening is withdrawal from accumulated meprobamate.¹⁸ Baclofen withdrawal can also be severe, producing spasticity, confusion, and even seizures. Adding a second muscle relaxant to any of these drugs deepens your physiological dependence on central-nervous-system suppression, making the eventual tapering process harder and more dangerous.

How Muscle Relaxants Are Actually Used in Practice

Despite the risks, muscle relaxants are widely prescribed. Data from commercially insured adults in the United States show that roughly 6 to 7 out of every 100 people fill a muscle-relaxant prescription in a given year. Cyclobenzaprine dominates, accounting for more than half of all prescriptions. About a third of users do not even have a recorded musculoskeletal diagnosis preceding the prescription, and the typical course of treatment is two weeks, with only a small fraction continuing past 90 days.⁷ These drugs are meant for short-term relief. The evidence for long-term use is thin, and the risk of side effects, dependence, and withdrawal goes up the longer you take them.

That short-term framing matters for the doubling-up question. If one muscle relaxant is not relieving your pain after a couple of weeks, the clinical response is generally not to add a second one. It is to reassess the underlying problem. Muscle relaxants are often started after first-line pain relievers like acetaminophen or ibuprofen have not worked well enough, and they are considered controversial alternatives that carry risks of side effects and increased cost. Escalation typically means physical therapy, targeted injections, or a different class of drug entirely rather than a second muscle relaxant.

Liver Enzymes and Why Your Metabolism Matters

Many muscle relaxants are processed by the same family of liver enzymes, particularly the cytochrome P450 system. When two drugs compete for the same enzyme, one or both can build up in your bloodstream to higher levels than expected. The interaction between tizanidine and CYP1A2 inhibitors described earlier is one example, but the pattern repeats across the class. Cyclobenzaprine is metabolized partly by CYP1A2 and CYP3A4. Carisoprodol is converted to meprobamate partly through CYP2C19. If you take two muscle relaxants that share a metabolic pathway, each one slows the breakdown of the other, effectively raising the dose of both.

Genetic variation adds another layer of unpredictability. People differ in how active their liver enzymes are. Someone who metabolizes drugs slowly is already getting a higher effective dose from a single prescription. Adding a second drug processed by the same sluggish enzyme could push blood levels into toxic territory without any outward warning until symptoms appear.

When Combining Two Agents Might Actually Happen Under Medical Supervision

There are narrow clinical situations where a physician might prescribe two agents that both relax muscles. A patient with severe spasticity from multiple sclerosis or a spinal cord injury, for example, might be on baclofen for baseline tone control and receive a one-time dose of dantrolene for an acute crisis. Dantrolene is unusual among muscle relaxants because it works directly on skeletal muscle rather than in the brain, so it does not compound central sedation in the same way. But even in these cases, the decision involves careful monitoring in a hospital or clinic setting, not a patient independently doubling up at home.

The key distinction is supervised combination therapy for a diagnosed neurological condition versus self-prescribing a second muscle relaxant because your back still hurts. The former involves dose adjustments, monitoring of vital signs, and awareness of each drug’s metabolic pathway. The latter is a gamble with compounding sedation, unpredictable drug levels, and no safety net.

What to Do If One Muscle Relaxant Is Not Enough

If your current muscle relaxant is not controlling your pain, do not reach for a second pill from a different prescription. Several options are worth discussing with your prescriber before escalating within the same drug class:

Dose adjustment: You may be on a subtherapeutic dose of your current muscle relaxant, and a modest increase under medical supervision could help more than adding a second drug.
Switching agents: If cyclobenzaprine is not working, tizanidine or methocarbamol might. Different drugs suit different people, and switching carries less risk than stacking.
Adding a different class: An anti-inflammatory like naproxen or a low-dose tricyclic antidepressant used off-label for pain may complement a muscle relaxant without duplicating its sedative load, though interactions still need to be checked.
Physical therapy: Exercise-based rehabilitation addresses the underlying cause of muscle spasm rather than masking it chemically, and it has fewer side effects than any drug.
Topical treatments: Menthol-based rubs, lidocaine patches, or topical anti-inflammatories can add a layer of relief that does not pass through the liver or affect the central nervous system.

The conversation with your prescriber is especially important if you have kidney disease, liver problems, or are taking opioids, benzodiazepines, or antidepressants. Each of those factors narrows the margin of safety for any muscle relaxant, and combining two of them under those circumstances compresses the margin further. If you have already taken two muscle relaxants and feel unusually drowsy, confused, or short of breath, that warrants urgent medical attention rather than a wait-and-see approach.